… of molnupiravir seen in preclinical studies and a phase 1 trial … The potential of molnupiravir
as an antiviral treatment for … phase 2/3 studies, one in outpatients (MOVe-OUT trial 9 , 10 ) …

… review and meta-analysis of randomized controlled trials that allocated adult patients with
non-severe COVID-19 to molnupiravir or a control. We used random-effects models, and …

… The Cochrane risk of bias tool for randomised trials was used to assess … randomised clinical
studies were included for a full evaluation of the efficacy and safety of molnupiravir treatment …

… of all randomly assigned participants, molnupiravir showed a … potential benefits of molnupiravir
for the treatment of mild to … all randomly assigned participants who received molnupiravir …

… Trials of molnupiravir have previously been done in largely unvaccinated participants …
Our trial provides an estimate of the effectiveness of molnupiravir in a multiply vaccinated …

… The effects of molnupiravir in treating patients with non-… In adult patients with mild or moderate
COVID-19, molnupiravir … Molnupiravir probably increases the rate of viral clearance (RR, …

… -blind, randomized, placebo-controlled trial to evaluate the efficacy and safety of treatment
with molnupiravir started … Participants in the trial were randomly assigned to receive 800 mg of …

… of molnupiravir for COVID-19 treatment in … trial indicated no reduction in the low rates for
hospitalization or death among vaccinated outpatients with risk factors treated with molnupiravir. …

… study, we performed a randomized, controlled study to evaluate the clinical efficacy of
molnupiravir … In our study, we found that molnupiravir was effective in treating COVID-19 caused …

… conducted to assess the clinical efficacy of molnupiravir in treating patients with COVID-19. …
In the present study, molnupiravir was effective in reducing the risks of mortality and …